Prostate Neoplasms Clinical Trials

45 clinical trials for Prostate Neoplasms across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Fusion Guided Focal Laser Ablation of Prostate Cancer — RECRUITING · NA
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer — RECRUITING · PHASE1
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures — RECRUITING · NA
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer — RECRUITING · PHASE1
Novel Therapy Target in Metastatic Prostate Cancer — RECRUITING
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy — COMPLETED · PHASE1
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer — COMPLETED · PHASE2
Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator — TERMINATED · NA
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC) — COMPLETED
Effects of Music and Conversation in Prostate Biopsy — COMPLETED · NA
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC) — COMPLETED · PHASE3
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients — COMPLETED · PHASE1
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors — TERMINATED · PHASE1
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment — COMPLETED · PHASE2
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution — COMPLETED · NA
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry — COMPLETED · NA
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer — COMPLETED · PHASE1
Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment — TERMINATED · PHASE2
Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases — TERMINATED · PHASE2
Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate Cancer — COMPLETED · NA
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer — COMPLETED · PHASE2
Prostate Cancer Stereotactic Radiotherapy — COMPLETED · NA
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy — COMPLETED · PHASE3
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer — OTHER · NA
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice — TERMINATED
A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer — TERMINATED
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer — COMPLETED · PHASE2
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) — COMPLETED · PHASE1
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer — OTHER
Evaluation of Truebeam for Low-Intermediate Risk Prostate Cancer — OTHER · PHASE4
Sipuleucel-T Manufacturing Demonstration Study — COMPLETED · PHASE2
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer — WITHDRAWN
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE2
An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasma — COMPLETED · PHASE2
An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy — COMPLETED · PHASE2
Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer — COMPLETED · PHASE1
PS-341 Followed by Removal of Prostate for Those With Prostate Cancer — COMPLETED · PHASE2
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer — COMPLETED · PHASE1
An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 — COMPLETED · PHASE1
A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer — COMPLETED · PHASE1
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE1
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE1
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer — COMPLETED · PHASE2

Refine this search